9
Jun 2026
Apitegromab helps tirzepatide users lose fat while preserving lean mass
A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus placebo after 24 weeks, while overall weight loss remained similar.







